Abstract: A switching DC-DC converter includes: an output voltage detecting unit configured to detect a DC output voltage; an error amplifying unit configured to compare the detected output voltage and a reference voltage and configured to supply an amplified error signal between the detected output voltage and the reference voltage to the pulse width modulating unit; and a single oscillating unit connected to an output of the output voltage detecting unit and an output of the error amplifying unit and operable on a first oscillating mode and a second oscillation mode. The oscillating unit on the first oscillating mode controls a switching frequency of the power switch based on the detected output voltage. The oscillating unit on the second oscillating mode controls the switching frequency of the power switch based on the amplified error signal.

Abstract: A compound represented by the formula (I): or a pharmacologically acceptable salt thereof, wherein Ar1 represents an imidazolyl group or the like which may be substituted with a C1-6 alkyl group, Ar2 represents a phenyl group or the like which may be substituted with a C1-6 alkoxy group, X1 represents a double bond or the like and Het represents a triazolyl group or the like which may be substituted with a C1-6 alkyl group or the like, is effective as a therapeutic or prophylactic agent for a disease caused by A?.

Abstract: An acid addition salt of 3-(2-cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one or a hydrate thereof, wherein the acid is selected from the group consisting of benzenesulfonic acid, p-toluenesulfonic acid, hydrochloric acid, hydrobromic acid, sulfuric acid, methanesulfonic acid, fumaric acid, tartaric acid, succinic acid and benzoic acid.

Abstract: The invention provides crystals of dihydrochloride monohydrate of the compound of the following formula having an A? production inhibiting effect which crystals are characterized by exhibiting a diffraction peak at an angle of diffraction (2?±0.2°) of 10.9° in powder X-ray diffractometry. Further, the invention also provides the compound in the form of various salts, crystal forms and amorphous forms which are suitable for the development of drugs.

Abstract: The present invention provides a most suitable prodrug of a cinnamide compound. The prodrug is represented by Formula (I) wherein Ra and Rb each denote a C1-6 alkyl group or the like; Xa denotes a methoxy group or a fluorine atom; Y denotes a phosphono group or the like; and A denotes a cyclic lactam derivative.

Abstract: According to one embodiment of the invention, there is provided an information processing apparatus including: an input acceptance unit configured to accept an input of an incoming call condition for causing another information processing apparatus connected to the information processing apparatus; a transmission unit configured to transmit information about the incoming call condition when a call is originated to another information processing apparatus; a determination unit configured to determine whether or not a line disconnection request for requesting disconnection of a line remaining connected to another information processing apparatus, until establishment of a connection to another information processing apparatus is completed; and a line disconnection unit configured to disconnect the line remaining connected to another information processing apparatus if the determination unit determines that the line disconnection request is acquired.

Abstract: A method for manufacturing a plugged honeycomb structure 30 which comprises attaching a mask film 4 to an end surface 11; making holes 3 at selected portions corresponding to the predetermined cell opening end portions 7; applying a pretreating agent 20 containing at least one component compatible with a dispersion medium for slurry for plugging the predetermined cell opening end portions 7 to partition walls 10 at the predetermined cell opening end portions 7, then submerging, in a plugging slurry 6, the end surface 11 of the material to which the perforated mask film 4 has been attached to fill the predetermined cell opening end portions 7 with the plugging slurry 6.

Abstract: An ophthalmic laser treatment apparatus comprises: a laser source that emits a laser beam for treatment of an affected part of a patient's eye; an optical fiber that transmits the laser beam emitted from the laser source; and a delivery optical system that irradiates the laser beam emitted from the optical fiber to the affected part of the patient's eye, the delivery optical system including: a plurality of diffraction optical elements each being configured to shape a beam profile of the laser beam at an emission end face of the optical fiber into a beam profile having one of a uniform intensity and a lower intensity in the center than on the periphery on the affected part and also to shape the laser beam to have a different spot size on the affected part of the patient's eye; and a changing unit which selectively disposing one of the diffraction optical elements on an optical path.

Abstract: A crystal of 1-[1-[2-(7-methoxy-2,2-dimethyl-4-oxochroman-8-yl)-ethyl]piperidin-4-yl]-N-methyl-1H-indole-6-carboxamide fumarate which has peaks at chemical shifts of about 124.0 ppm and about 26.8 ppm in a 13C solid NMR spectrum.

Abstract: The present invention relates to a compound represented by formula (I): wherein R1 represents a C1-3 alkyl group, R2 represents a hydrogen atom or a C1-3 alkyl group, Ar represents a phenyl group or the like which may be substituted with 1 to 3 substituents, X represents an oxygen atom or the like, n and m are the same or different and integers of 0 to 2, or a pharmacologically acceptable salt, and use thereof as a medicament.

Abstract: In a mobile terminal provided with an encoded data recording function, there is assumed a condition in which a picture frame transmitted from the terminal of a communication partner is reproduced by means of decoding processing and is displayed on a LCD (34) during wireless TV phone communication. In this condition, when a user carries out a picture recording start operation, display picture data reproduced by means of decoding processing in the multimedia processing section (24) to be displayed on the LCD (34) are recorded in a main recording section (26).

Abstract: A method of manufacturing a plugged honeycomb structure 30 including a honeycomb substrate 1 and plugging portions 15 arranged so as to form complementary checkered patterns at both end surfaces 11 and 21 of the honeycomb substrate 1; which comprises attaching a first mask film 4a to the first end surface 11 of the honeycomb substrate 1, making slurry permeation holes 3a to introduce a plugging slurry 6, attaching a second mask film 4b to the second end surface 21 of the honeycomb substrate 1, makes slurry permeation holes 3b, allowing air to flow into the cells 2 so as to discharge air giving a pressure of 0.05 to 5 MPa between the first mask film 4a and the honeycomb substrate 1; and filling cell opening end portions 7 with the plugging slurry 6 to fire the resultant slurry filled substrate 20.

Abstract: A manufacturing method of a plugged honeycomb structure 30 which comprises a honeycomb substrate 1 and plugging portions 15 arranged so as to form complementary checkered patterns alternately at both end surfaces 11 and 21 of the honeycomb substrate 1. The method comprises attaching mask films 4a and 4b to both end surfaces 11 and 21 of the honeycomb substrate 1, respectively; forming slurry permeation holes 3a at portions of the mask films 4a and 4b corresponding to cell opening end portions 7, respectively; forming deaeration holes 3b at portions of the mask films 4a and 4b facing the portions provided with the slurry permeation holes 3a via cells 2; submerging both end surfaces 11 and 21 of the honeycomb substrate 1 to which the mask films 4a and 4b have been attached into a plugging slurry 6, respectively; and firing the resultant slurry filled substrate 20.

Abstract: A manufacturing method of a plugged honeycomb structure comprising; attaching a transparent sheet to an end face of a honeycomb structure; picking up an image of the end face; with respect to cells 9c positioned at other than outermost peripheral portion of a honeycomb structure (usual cells), subjecting the picked-up image to image processing, recognizing positions to be plugged on said sheet, and with respect to cells 9d positioned at outermost peripheral portion (outermost peripheral cells), positions of the cells 9d are recognized based on an average cell pitch calculated from the positions of the cells 9c, subjecting to a perforation treatment based on the recognized positions of the sheet, submerging an end portion into a plugging slurry in which a material of the plugging portions is slurried, filling holes made at the respective sheet with the slurry to form the plugging portions.

Abstract: The encryption device includes a random number generator for generating a random number; and a first selector for selecting one of q fixed values in response to the random number, a second selector for selecting one set of q sets of fixed S-box tables in response to the random number. An XOR XORs an input with an XOR of a key with the fixed value. A nonlinear transform transforms an input nonlinearly in accordance with the selected set of fixed S-box tables. Another encryption device includes a plurality of encrypting units coupled in parallel, and a selector for selecting one of the plurality of encrypting units in response to the random number. The masking with the fixed values improves the processing speed and reduces the required RAM area.

Abstract: The present invention provides a compound represented by the formula (1) or a pharmacologically acceptable salt thereof, or a hydrate thereof (provided that a compound in which all of R4a, R4b, and R4c are hydrogen atoms is excluded.): [wherein R1 represents a hydrogen atom, R2 represents a hydrogen atom, R3 represents the formula: wherein R4a, R4b, and R4c are the same as or different from each other and each represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, etc.

Abstract: In a mobile terminal provided with an encoded data recording function, there is assumed a condition in which a picture frame transmitted from the terminal of a communication partner is reproduced by means of decoding processing and is displayed on a LCD (34) during wireless TV phone communication. In this condition, when a user carries out a picture recording start operation, display picture data reproduced by means of decoding processing in the multimedia processing section (24) to be displayed on the LCD (34) are recorded in a main recording section (26).

Abstract: A fishing lure includes a lure body which is formed in an appearance imitating a small fish. A lower jaw which is vertically pivotable is provided on the front end of the lure body, and the pivot angle of the lower jaw is adjustable. The lower jaw is pivotally supported by the lure body at the base, and has an angle adjusting mechanism to control the pivot angle of the lower jaw around the pivot.

Abstract: A fishing lure includes a lure body formed to have an appearance imitating a small fish. The lure body is provided with a bendably structured diving plate in the vicinity of the tip of the lure body. The diving plate is made to be bendable by connecting the upper portion and the lower portion of the diving plate bendably in a manner that the lower portion is vertically pivotable in regard to the upper portion fixed on the lure body.

Abstract: The present invention relates to a compound represented by Formula (I): (wherein Ar1 represents an imidazolyl group which may be substituted with 1 to 3 substituents; Ar2 represents a pyridinyl group, a pyrimidinyl group, or a phenyl group which may be substituted with 1 to 3 substituents; X1 represents (1) —C?C— or (2) a double bond etc. which may be substituted; R1 and R2 represent, for example, a C1-6 alkyl group or C3-8 cycloalkyl group which may be substituted) or a pharmacologically acceptable salt thereof and to the use thereof as pharmaceutical agents.